Blood Biomarkers of Long COVID: A Systematic Review
Journal article
Authors | Callum Thomas, Mark A. Faghy, Corinna Chidley, Bethan E. Phillips, Thomas Bewick and Ruth E Ashton |
---|---|
Abstract | Long coronavirus disease (COVID; LC) affects millions of people worldwide. The exact mechanisms which result in a broad, undulating and detrimental symptom profile remain unknown. Blood biomarkers associated with LC have been described; however, consensus on these remains elusive, in part due to a lack of continuity between studies on a universally accepted definition of LC. This systematic review aimed to consolidate current knowledge of blood biomarkers associated with the prevalence of LC on the basis of the World Health Organisation (WHO) clinical definition of this condition. Eligibility criteria for selecting studies: Observational, cross-sectional, and randomised control studies published in the English language that studied blood biomarkers associated with the WHO definition of LC. All studies included participants who were ≥ 18 years old and group sizes ≥ 10 participants, and were compared against a control group without any known co-morbidities. |
Keywords | Long coronavirus disease ; Blood biomarkers ; Covid-19 |
Year | 2024 |
Journal | Molecular Diagnosis & Therapy |
Journal citation | pp. 1-38 |
Publisher | Springer |
ISSN | 1179-2000 |
Digital Object Identifier (DOI) | https://doi.org/10.1007/s40291-024-00731-z |
Web address (URL) | https://pureportal.coventry.ac.uk/en/publications/blood-biomarkers-of-long-covid-a-systematic-review |
https://doi.org/10.1007/s40291-024-00731-z | |
Output status | Published |
Publication dates | 05 Aug 2024 |
Publication process dates | |
Deposited | 16 Aug 2024 |
https://repository.derby.ac.uk/item/q7vw6/blood-biomarkers-of-long-covid-a-systematic-review
18
total views0
total downloads2
views this month0
downloads this month